D Speake

NHS Lothian, Western General Hospital

Papers

2

Total Citations

77

H-Index

2

About

David Speake is a colorectal surgeon whose work sits at the intersection of surgical innovation and enhanced recovery. His research focuses on two pivotal areas: the clinical implementation of robotic surgical systems and the optimization of postoperative gastrointestinal recovery. Speake’s major contribution to the field is his pioneering clinical adoption of the Versius robotic surgical system for colorectal cancer surgery. His 2021 paper, detailing the first clinical experience with this UK-based platform, has garnered 63 citations, establishing a foundational benchmark for robotic colorectal procedures. In parallel, Speake has driven forward the science of perioperative care. He is the lead investigator of the ALLEGRO trial, a landmark placebo-controlled randomized study exploring intravenous lidocaine’s role in accelerating gastrointestinal recovery after colorectal surgery—a critical step in reducing postoperative ileus and shortening hospital stays. With 14 citations, this work addresses a fundamental patient-centered outcome. Speake’s dual focus on cutting-edge technology and evidence-based recovery pathways positions him as a key figure shaping modern, safer colorectal surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
77
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
Implementation of the Versius robotic surgical system for colorectal cancer surgery: First clinical experience
63 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: NHS Lothian, Western General Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago